You just read:

Daiichi Sankyo Presents Preliminary Phase 1 Data for TROP2 Targeting ADC DS-1062 in Patients with Non-Small Cell Lung Cancer at 2019 ASCO Annual Meeting

News provided by

Daiichi Sankyo Company, Limited

Jun 02, 2019, 08:00 ET